Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats.
Germ-free rats colonised with a human intestinal flora were fed diets containing high risk (HR) or low risk (LR) factors for colorectal cancer, and putative biomarkers were evaluated in the colonic mucosa; (i) proliferation, (ii) 1,2-dimethylhydrazine (DMH)-induced aberrant crypt foci and (iii) DMH-induced DNA damage. The HR diet was high in fat (45% of calories) and low in calcium and fibre, reflecting levels characteristic of typical western diets. The LR diet was low in fat (<5% of calories), and high in calcium and fibre. The nutrient/energy ratio of the two diets were similar. Mucosal crypt cell proliferation, assessed after microdissection, was higher on the LR diet (mean number of mitoses per crypt was 2.65 on the LR diet, and 1.62 on the HR diet; P < 0.05). Aberrant crypt foci (ACF) were assessed in the mucosa 12 weeks after DMH treatment. On the HR diet there were significantly more small ACF with 1 and 2 crypts per focus, but fewer ACF with 3, 5 and 7 or more crypts per focus. There was no significant difference in total ACF or the total number of crypts. The effect of diet on DNA damage in the colon was assessed in vivo by the comet assay. Animals were fed a HR or LR diet for 12 weeks before treatment with DMH or saline. For carcinogen-treated animals, DNA damage was significantly higher in colon cells from animals on the HR diet. On the LR diet both DNA damage and the induction of small ACF were reduced despite an increase in cell proliferation. The increase in large ACF on the LR diet may be attributable to elevated crypt cell proliferation possibly increasing crypt fission rates.
Hambly
R J
RJ
BIBRA International, Carshalton, Surrey, UK.
Rumney
C J
CJ
Cunninghame
M
M
Fletcher
J M
JM
Rijken
P J
PJ
Rowland
I R
IR
D019813:1,2-Dimethylhydrazine; D000818:Animals; D001419:Bacteria; D015415:Biomarkers / Q000032:analysis*; D001835:Body Weight / Q000187:drug effects; D003106:Colon / Q000187:drug effects / Q000473:pathology*; D003108:Colonic Diseases / Q000139:chemically induced / Q000235:genetics / Q000473:pathology*; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000473:pathology*; D004247:DNA / Q000187:drug effects; D004032:Diet / Q000009:adverse effects*; D004127:Dimethylhydrazines; D004195:Disease Models, Animal; D005260:Female; D005526:Food, Formulated; D005856:Germ-Free Life; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008940:Mitotic Index / Q000187:drug effects; D011230:Precancerous Conditions / Q000139:chemically induced / Q000473:pathology*; D051381:Rats; D011916:Rats, Inbred F344; D012307:Risk Factors
D015415:Biomarkers; D004127:Dimethylhydrazines; D004247:DNA; D019813:1,2-Dimethylhydrazine